SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-449990
Filing Date
2013-11-21
Accepted
2013-11-21 17:18:06
Documents
3
Period of Report
2013-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d633425d8k.htm 8-K 14959
2 EX-99.1 d633425dex991.htm EX-99.1 3197
3 GRAPHIC g633425g42l43.jpg GRAPHIC 3413
  Complete submission text file 0001193125-13-449990.txt   24437
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 131236060
SIC: 2835 In Vitro & In Vivo Diagnostic Substances